All Stories

  1. Cryo-EM structure of the Ebola virus nucleoprotein–RNA complex
  2. Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
  3. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain
  4. Crystal Structure of the Oligomeric Form of Lassa Virus Matrix Protein Z
  5. Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression
  6. Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression
  7. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein
  8. Structure of theReston ebolavirusVP30 C-terminal domain
  9. Lassa Fever in Post-Conflict Sierra Leone
  10. Correction: The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
  11. IgG hexamerization mediates efficient C1q docking and complement-dependent cytotoxicity (CDC)
  12. Crystal structure of the Nipah virus phosphoprotein tetramerization domain
  13. An update on the use of antibodies against the filoviruses
  14. Crystal Structure of the Nipah Virus Phosphoprotein Tetramerization Domain
  15. Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013
  16. Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle
  17. Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism
  18. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
  19. Two Synthetic Antibodies that Recognize and Neutralize Distinct Proteolytic Forms of the Ebola Virus Envelope Glycoprotein
  20. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
  21. Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism
  22. Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease
  23. The ebolavirus VP24 interferon antagonist
  24. Structural Basis for Differential Neutralization of Ebolaviruses
  25. Editorial overview
  26. Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses
  27. The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
  28. Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus
  29. A shared structural solution for neutralizing ebolaviruses
  30. Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion
  31. Crystal structure of the Lassa virus nucleoprotein–RNA complex reveals a gating mechanism for RNA binding
  32. Measles virus fusion shifts into gear
  33. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression
  34. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression
  35. Ebolavirusglycoprotein structure and mechanism of entry
  36. Techniques and tactics used in determining the structure of the trimericebolavirusglycoprotein
  37. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it
  38. An efficient platform for screening expression and crystallization of glycoproteins produced in human cells
  39. Erica Ollmann Saphire
  40. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
  41. Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light Chain
  42. Structure of a High-affinity “Mimotope” Peptide Bound to HIV-1-neutralizing Antibody b12 Explains its Inability to Elicit gp120 Cross-reactive Antibodies
  43. Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling
  44. gp41: HIV's shy protein
  45. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
  46. The Carbohydrate Epitope of the Neutralizing Anti-HIV-1 Antibody 2G12
  47. Crystal Structure of an Intact Human IgG: Antibody Asymmetry, Flexibility, and a Guide for HIV-1 Vaccine Design
  48. Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120
  49. The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120
  50. Contrasting IgG Structures Reveal Extreme Asymmetry and Flexibility
  51. GP120: Biologic Aspects of Structural Features
  52. Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1